Legionella Testing Market Size by Test Type (Culture, Urinary Antigen Test, DFA, PCR), Application (Water & IVD Testing (Urine, Blood)), End User (Hospitals, Clinics, Diagnostic Labs, Water Treatment Industries), Region - Global Forecast to 2027
The global size of legionella testing market in terms of revenue was estimated to be worth USD 296.0 million in 2022 and is poised to reach USD 439.0 million by 2027, growing at a CAGR of 8.2% from 2022 to 2027. The research study consists of an industry trend analysis, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.
The rising geriatric population, combined with the rising prevalence of legionella-related illness and rising demand for rapid diagnostics, is driving growth in this market.
To know about the assumptions considered for the study, Request for Free Sample Report
Legionella Testing Market Dynamics
Driver: Rapid increase of pneumonia and Legionella-related illnesses
According to the European Centre for Disease Prevention and Control (ECDC) (May 2022), Legionnaires' disease remains an uncommon and mainly sporadic respiratory infection with an overall notification rate of 1.9 cases per 100,000 population for the EU/EEA in 2020. France, Germany, Italy, and Spain accounted for 72% of all notified cases. In addition, according to the US CDC (March 2022), the age-standardized average incidence was 0.48 cases per 100,000 population during 1992–2002, compared with 2.71/100,000 in 2018.
Opportunity: Legal requirements for water testing
The Environment Protection Agency (EPA) (October 2021) sets legal limits on over 90 contaminants in the US for drinking water. The legal limit for a contaminant reflects the level that protects human health and that water systems can achieve using the best available technology. EPA rules also set water-testing schedules and methods that water systems must follow. In addition, the Safe Drinking Water Act (SDWA) allows individual states to set and enforce their own drinking water standards if the standards are at least as stringent as the EPA's national standards.
Restraint: lack of reimbursement policies
The major factor restraining the growth of the market is inadequate reimbursements. According to MedPAC (Medicare Payment Advisory Commission), medical testing has seen a 40% decline in reimbursement over the last 40 years. This decline and additional budgetary concerns among healthcare systems will be a major obstacle to implementing novel diagnostic techniques in clinical laboratories.
Challenge: Difficulties in detection
The most common cause of Legionnaire's disease is Legionella pneumophilia serogroup 1, which can be quickly and easily identified via the urine antigen test. Legionnaire's disease can also go undetected once a patient is diagnosed with pneumonia. Best practises dictate that all hospital-acquired pneumonia patients be tested for Legionella in hopes of detecting and preventing a possible outbreak.
The PCR segment accounted for the largest share of the legionella testing industry, by test type.
The legionella testing market is segmented into culture methods, urinary antigen tests, direct fluorescent antibody tests, and PCR. The PCR accounted for the largest share of the market, mainly due to its versatility, speed, and simplicity.
Water testing accounted for the largest share of legionella testing industry by application.
The legionella testing market has been segmented into water testing, IVD testing, and other applications. The water testing segment will account for the largest share of the market. Factors such as the changes in lifestyle around the globe and the rising elderly population are driving the growth of the market.
The water and other industries segment accounted for the largest share of the legionella testing industry by end user.
The legionella testing market has been segmented into hospitals, diagnostic laboratories, water and other industries, and other end users. The water and other industries segment accounted for the largest share of the market. The strict water treatment regulations, increasing population and urbanization, and the increased need for new water resources are driving the growth of this segment.
North America is the largest region in the legionella testing industry.
The legionella testing market is segmented into five major regions: North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. North America will account for the largest share of the market. The growth of the North American market can be attributed to the growing elderly population coupled with rising legionella-related illnesses.
To know about the assumptions considered for the study, download the pdf brochure
Prominent players in the legionella testing market are Thermo Fisher Scienific, Inc. (US), Merck KGaA (Germany), Becton, Dickinson, and Company (US), Roche Diagnostics (Switzerland), Pall Corporation (US)
Scope of the Legionella Testing Industry
|
Report Metric |
Details |
|
Market Revenue in 2022 |
USD 296.0 million |
|
Projected Revenue by 2027 |
USD 439.0 million |
|
Revenue Rate |
Poised to Grow at a CAGR of 8.2% |
|
Market Driver |
Rapid increase of pneumonia and Legionella-related illnesses |
|
Market Opportunity |
Legal requirements for water testing |
This report categorizes the global legionella testing market into the following segments and sub-segments
By Test Type
- Culture Methods
- Urinary Antigen Tests
- Direct Fluorescent Antibody Tests
-
PCR
- Motorized Devices
- Non-Motorized Devices
By Application
-
Water Testing
- Microbial Culture
- DFA Stain
- PCR
-
IVD Testing
- Blood Culture and Sputum Tests
- Urinary Antigen Tests
- DFA Stain
- PCR
- Other Applications
By End User
- Hospitals
- Diagnostic Laboratories
- Water & Other Industries
- Other End Users
By Region
-
North America
- US
- Canada
-
Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe
-
Asia Pacific
- China
- Japan
- India
- Rest of Asia Pacific
- Latin America
- Middle East & Africa
Recent Developments of Legionella Testing Industry
- In December 2021, IDEXX Laboratories, Inc. (US) acquired Reference Laboratories (Finland) to expanded the company’s international reference laboratory presence.
- In November 2020, LuminUltra Technologies Ltd. (Canada) launched launched GeneCount qPCR, a rapid onsite molecular testing solution.
- In September 2020, Eurofins Scientific (Luxembourg) acquired SunDream Group (Taiwan) to boost its environmental testing capabilities, as SunDream is the second-largest player in the environmental testing segment in Taiwan.
Frequently Asked Questions (FAQ):
What is the projected market revenue value of the global legionella testing market?
The global legionella testing market boasts a total revenue value of USD 439.0 million by 2027.
What is the estimated growth rate (CAGR) of the global legionella testing market?
The global market for legionella testing has an estimated compound annual growth rate (CAGR) of 8.2% and a revenue size in the region of USD 296.0 million in 2022.
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
TABLE OF CONTENTS
1 INTRODUCTION (Page No. - 27)
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
TABLE 1 INCLUSIONS AND EXCLUSIONS
1.3 STUDY SCOPE
1.4 YEARS CONSIDERED
1.5 CURRENCY CONSIDERED
1.6 LIMITATIONS
1.7 STAKEHOLDERS
2 RESEARCH METHODOLOGY (Page No. - 30)
2.1 RESEARCH DATA
FIGURE 1 LEGIONELLA TESTING MARKET: RESEARCH DESIGN METHODOLOGY
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key data from primary sources
TABLE 2 KEY DATA FROM PRIMARY SOURCES
FIGURE 2 KEY INDUSTRY INSIGHTS
2.1.2.2 Breakdown of primary interviews
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS (GLOBAL MARKET)
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
2.2.1 BOTTOM-UP APPROACH
2.2.1.1 Approach 1: Company revenue estimation approach
FIGURE 5 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH
2.2.1.2 Approach 2: Presentations of companies and primary interviews
2.2.1.3 Growth forecast
2.2.1.4 CAGR projections
FIGURE 6 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
2.2.2 TOP-DOWN APPROACH
FIGURE 7 GLOBAL MARKET: TOP-DOWN APPROACH
2.3 DATA TRIANGULATION
FIGURE 8 DATA TRIANGULATION METHODOLOGY
2.4 RESEARCH ASSUMPTIONS
2.5 LIMITATIONS AND RISK ASSESSMENT
FIGURE 9 LIMITATIONS: GLOBAL MARKET
TABLE 3 RISK ASSESSMENT: GLOBAL MARKET
3 EXECUTIVE SUMMARY (Page No. - 42)
FIGURE 10 GLOBAL MARKET FOR LEGIONELLA TESTING, BY TEST TYPE, 2022 VS. 2027 (USD MILLION)
FIGURE 11 GLOBAL LEGIONELLA TESTING INDUSTRY FOR LEGIONELLA TESTING, BY APPLICATION, 2022 VS. 2027 (USD MILLION)
FIGURE 12 GLOBAL MARKET FOR LEGIONELLA TESTING, BY END USER, 2022 VS. 2027 (USD MILLION)
FIGURE 13 GLOBAL MARKET FOR LEGIONELLA TESTING, BY REGION, 2022 VS. 2027 (USD MILLION)
4 PREMIUM INSIGHTS (Page No. - 45)
4.1 MARKET OVERVIEW
FIGURE 14 GROWING PREVALENCE OF LEGIONELLA-RELATED ILLNESS AND RISING GERIATRIC POPULATION TO DRIVE MARKET GROWTH
4.2 GLOBAL LEGIONELLA TESTING INDUSTRY SHARE, BY TEST TYPE, 2022 VS. 2027
FIGURE 15 PCR SEGMENT WILL CONTINUE TO DOMINATE MARKET IN 2027
4.3 GLOBAL MARKET SHARE, BY APPLICATION, 2022 VS. 2027
FIGURE 16 WATER TESTING SEGMENT TO HOLD LARGEST MARKET SHARE
4.4 GLOBAL MARKET SHARE, BY END USER, 2022 VS. 2027
FIGURE 17 WATER & OTHER INDUSTRIES TO CONTINUE TO DOMINATE MARKET IN 2027
4.5 GLOBAL MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 18 ASIA PACIFIC TO REGISTER HIGHEST GROWTH RATE
5 MARKET OVERVIEW (Page No. - 48)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 19 LEGIONELLA TESTING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Rising incidence of pneumonia and legionella-related illnesses
5.2.1.2 Increasing demand for rapid advanced diagnostic technologies
5.2.1.3 Technological advancements in bacterial testing
5.2.1.4 Stringent regulations for regular water testing
5.2.2 RESTRAINTS
5.2.2.1 Lack of reimbursement policies
5.2.3 OPPORTUNITIES
5.2.3.1 Opportunities in growing economies
5.2.3.2 Legal requirements for water testing
5.2.4 CHALLENGES
5.2.4.1 Difficulties in detection
5.2.4.2 Limited awareness in underdeveloped countries
5.2.4.3 High health costs associated with Legionella
5.3 PRICING ANALYSIS
TABLE 4 AVERAGE SELLING PRICE OF LEGIONELLA TESTING PRODUCTS (2022)
5.4 PATENT ANALYSIS
FIGURE 20 PATENT ANALYSIS FOR MOTORIZED LEGIONELLA TESTING DEVICES
TABLE 5 LIST OF KEY PATENTS
5.5 VALUE CHAIN ANALYSIS
FIGURE 21 VALUE CHAIN ANALYSIS: MAJOR VALUE IS ADDED DURING MANUFACTURING AND ASSEMBLY PHASES
5.6 SUPPLY CHAIN ANALYSIS
FIGURE 22 GLOBAL MARKET FOR LEGIONELLA TESTING: SUPPLY CHAIN ANALYSIS
5.7 ECOSYSTEM/MARKET MAP
FIGURE 23 GLOBAL MARKET FOR LEGIONELLA TESTING: ECOSYSTEM/MARKET MAP
TABLE 6 GLOBAL LEGIONELLA TESTING INDUSTRY FOR LEGIONELLA TESTING: ROLE IN ECOSYSTEM
5.8 PORTER’S FIVE FORCES ANALYSIS
TABLE 7 GLOBAL MARKET FOR LEGIONELLA TESTING: PORTER’S FIVE FORCES ANALYSIS
5.8.1 THREAT OF NEW ENTRANTS
5.8.2 THREAT OF SUBSTITUTES
5.8.3 BARGAINING POWER OF BUYERS
5.8.4 BARGAINING POWER OF SUPPLIERS
5.8.5 DEGREE OF COMPETITION
5.9 PESTEL ANALYSIS
5.9.1 POLITICAL FACTORS
5.9.2 ECONOMIC FACTORS
5.9.3 SOCIAL FACTORS
5.9.4 TECHNOLOGICAL FACTORS
5.9.5 ENVIRONMENTAL FACTORS
5.9.6 LEGAL FACTORS
5.10 REGULATORY LANDSCAPE
TABLE 8 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 9 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 10 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 11 LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 12 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.10.1 NORTH AMERICA
5.10.1.1 US
5.10.1.2 Canada
5.10.2 EUROPE
5.10.3 ASIA PACIFIC
5.10.3.1 Japan
5.10.3.2 India
5.10.4 LATIN AMERICA
5.10.4.1 Brazil
5.10.4.2 Mexico
5.10.5 MIDDLE EAST
5.10.6 AFRICA
5.11 TRADE ANALYSIS
5.11.1 TRADE ANALYSIS FOR DIAGNOSTIC AND LABORATORY REAGENTS
TABLE 13 IMPORT DATA FOR DIAGNOSTIC AND LABORATORY REAGENTS, BY COUNTRY, 2017–2021 (USD MILLION)
TABLE 14 EXPORT DATA FOR DIAGNOSTIC AND LABORATORY REAGENTS, BY COUNTRY, 2017–2021 (USD MILLION)
5.12 TECHNOLOGY ANALYSIS
5.13 KEY CONFERENCES & EVENTS IN 2022–2023
TABLE 15 GLOBAL MARKET FOR LEGIONELLA TESTING: DETAILED LIST OF CONFERENCES & EVENTS
5.14 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
FIGURE 24 REVENUE SHIFT IN THE GLOBAL MARKET FOR LEGIONELLA TESTING
5.15 KEY STAKEHOLDERS & BUYING CRITERIA
5.15.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 25 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS OF LEGIONELLA TESTING PRODUCTS
TABLE 16 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS OF LEGIONELLA TESTING PRODUCTS
5.15.2 BUYING CRITERIA
FIGURE 26 KEY BUYING CRITERIA FOR LEGIONELLA TESTING PRODUCTS
TABLE 17 KEY BUYING CRITERIA FOR LEGIONELLA TESTING PRODUCTS
5.16 CASE STUDIES
6 GLOBAL LEGIONELLA TESTING MARKET, BY TEST TYPE (Page No. - 75)
6.1 INTRODUCTION
TABLE 18 GLOBAL LEGIONELLA TESTING INDUSTRY, BY TEST TYPE, 2020–2027 (USD MILLION)
6.2 PCR
6.2.1 INCREASED USAGE OF PCR TO SUPPORT MARKET GROWTH
TABLE 19 KEY PCR PRODUCTS AVAILABLE IN THE MARKET
TABLE 20 GLOBAL MARKET FOR PCR, BY REGION, 2020–2027 (USD MILLION)
6.3 CULTURE METHODS
6.3.1 HIGHER SPECIFICITY AND SENSITIVITY TO DRIVE MARKET
TABLE 21 KEY CULTURE METHODS AVAILABLE IN THE MARKET
TABLE 22 GLOBAL MARKET FOR CULTURE METHODS, BY REGION, 2020–2027 (USD MILLION)
6.4 URINARY ANTIGEN TESTS
6.4.1 RAPID OUTCOMES TO DRIVE MARKET GROWTH
TABLE 23 KEY URINARY ANTIGEN TESTS AVAILABLE IN THE MARKET
TABLE 24 GLOBAL MARKET FOR URINARY ANTIGEN TESTS, BY REGION, 2020–2027 (USD MILLION)
6.5 DIRECT FLUORESCENT ANTIBODY TESTS
6.5.1 RAPIDITY AND EASE OF USE TO BOOST ADOPTION OF TESTS
TABLE 25 GLOBAL MARKET FOR DIRECT FLUORESCENT ANTIBODY TESTS, BY REGION, 2020–2027 (USD MILLION)
7 GLOBAL LEGIONELLA TESTING MARKET, BY APPLICATION (Page No. - 81)
7.1 INTRODUCTION
TABLE 26 GLOBAL LEGIONELLA TESTING INDUSTRY FOR LEGIONELLA TESTING, BY APPLICATION, 2020–2027 (USD MILLION)
7.2 WATER TESTING
TABLE 27 GLOBAL MARKET FOR LEGIONELLA TESTING FOR WATER TESTING, BY TYPE, 2020–2027 (USD MILLION)
TABLE 28 GLOBAL MARKET FOR LEGIONELLA TESTING FOR WATER TESTING, BY REGION, 2020–2027 (USD MILLION)
7.2.1 PCR
7.2.1.1 Rapid diagnosis to spur segment growth
TABLE 29 WATER TESTING MARKET FOR PCR, BY REGION, 2020–2027 (USD MILLION)
7.2.2 MICROBIAL CULTURE
7.2.2.1 Long incubation periods make isolation difficult, affecting adoption of culture techniques
TABLE 30 WATER TESTING MARKET FOR MICROBIAL CULTURE, BY REGION, 2020–2027 (USD MILLION)
7.2.3 DFA STAIN
7.2.3.1 High test specificity to drive adoption of DFA staining
TABLE 31 WATER TESTING MARKET FOR DFA STAIN, BY REGION, 2020–2027 (USD MILLION)
7.3 IVD TESTING
TABLE 32 GLOBAL MARKET FOR IVD TESTING, BY TYPE, 2020–2027 (USD MILLION)
TABLE 33 GLOBAL MARKET FOR IVD TESTING, BY REGION, 2020–2027 (USD MILLION)
7.3.1 URINE ANTIGEN TESTS
7.3.1.1 Rapid and early diagnosis capabilities to drive market growth
TABLE 34 IVD TESTING MARKET FOR URINE ANTIGEN TESTS, BY REGION, 2020–2027 (USD MILLION)
7.3.2 PCR
7.3.2.1 Emergence of advanced technologies such as qRT-PCR to support market growth
TABLE 35 IVD TESTING MARKET FOR PCR, BY REGION, 2020–2027 (USD MILLION)
7.3.3 BLOOD CULTURE & SPUTUM TESTS
7.3.3.1 Longer incubation period resulting in lower adoption of blood culture techniques
TABLE 36 IVD TESTING MARKET FOR BLOOD CULTURE & SPUTUM TESTS, BY REGION, 2020–2027 (USD MILLION)
7.3.4 DFA STAIN
7.3.4.1 Sensitivity variations affect use of DFA staining in IVD tests
TABLE 37 IVD TESTING MARKET FOR DFA STAIN, BY REGION, 2020–2027 (USD MILLION)
7.4 OTHER APPLICATIONS
TABLE 38 GLOBAL MARKET FOR OTHER APPLICATIONS, BY REGION, 2020–2027 (USD MILLION)
8 GLOBAL LEGIONELLA TESTING MARKET, BY END USER (Page No. - 92)
8.1 INTRODUCTION
TABLE 39 GLOBAL LEGIONELLA TESTING INDUSTRY FOR LEGIONELLA TESTING, BY END USER, 2020–2027 (USD MILLION)
8.2 WATER & OTHER INDUSTRIES
8.2.1 STRINGENT REGULATIONS AND GROWING POPULATION TO DRIVE MARKET GROWTH
TABLE 40 GLOBAL MARKET FOR WATER & OTHER INDUSTRIES, BY REGION, 2020–2027 (USD MILLION)
8.3 DIAGNOSTIC LABORATORIES
8.3.1 HEALTHCARE INFRASTRUCTURE IMPROVEMENTS TO BOOST MARKET GROWTH
TABLE 41 GLOBAL MARKET FOR DIAGNOSTIC LABORATORIES, BY REGION, 2020–2027 (USD MILLION)
8.4 HOSPITALS
8.4.1 INCREASING ADOPTION OF DIAGNOSTIC TOOLS TO SUPPORT MARKET GROWTH
TABLE 42 GLOBAL MARKET FOR HOSPITALS, BY REGION, 2020–2027 (USD MILLION)
8.5 OTHER END USERS
TABLE 43 GLOBAL MARKET FOR OTHER END USERS, BY REGION, 2020–2027 (USD MILLION)
9 GLOBAL LEGIONELLA TESTING MARKET, BY REGION (Page No. - 97)
9.1 INTRODUCTION
TABLE 44 GLOBAL LEGIONELLA TESTING INDUSTRY, BY REGION, 2020–2027 (USD MILLION)
9.2 NORTH AMERICA
FIGURE 27 NORTH AMERICA: MARKET SNAPSHOT
TABLE 45 NORTH AMERICA: GLOBAL MARKET FOR LEGIONELLA TESTING, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 46 NORTH AMERICA: GLOBAL MARKET FOR LEGIONELLA TESTING, BY TEST TYPE, 2020–2027 (USD MILLION)
TABLE 47 NORTH AMERICA: GLOBAL MARKET FOR LEGIONELLA TESTING, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 48 NORTH AMERICA: MARKET, BY END USER, 2020–2027 (USD MILLION)
9.2.1 US
9.2.1.1 Strong presence of major market players to drive growth
TABLE 49 US: LEGIONELLA TESTING INDUSTRY, BY TEST TYPE, 2020–2027 (USD MILLION)
TABLE 50 US: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 51 US: MARKET FOR WATER TESTING, BY TYPE, 2020–2027 (USD MILLION)
TABLE 52 US: MARKET FOR IVD TESTING, BY TYPE, 2020–2027 (USD MILLION)
TABLE 53 US: MARKET, BY END USER, 2020–2027 (USD MILLION)
9.2.2 CANADA
9.2.2.1 Rising incidence of lifestyle diseases to drive market growth
TABLE 54 CANADA: LEGIONELLA TESTING MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)
TABLE 55 CANADA: LEGIONELLA TESTING INDUSTRY, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 56 CANADA: MARKET FOR WATER TESTING, BY TYPE, 2020–2027 (USD MILLION)
TABLE 57 CANADA: MARKET FOR IVD TESTING, BY TYPE, 2020–2027 (USD MILLION)
TABLE 58 CANADA: GLOBAL MARKET FOR LEGIONELLA TESTING, BY END USER, 2020–2027 (USD MILLION)
9.3 EUROPE
TABLE 59 EUROPE: LEGIONELLA TESTING INDUSTRY, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 60 EUROPE: MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)
TABLE 61 EUROPE: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 62 EUROPE: MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.1 GERMANY
9.3.1.1 Germany dominates Legionella testing market in Europe
TABLE 63 GERMANY: LEGIONELLA TESTING INDUSTRY, BY TEST TYPE, 2020–2027 (USD MILLION)
TABLE 64 GERMANY: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 65 GERMANY: MARKET FOR WATER TESTING, BY TYPE, 2020–2027 (USD MILLION)
TABLE 66 GERMANY: MARKET FOR IVD TESTING, BY TYPE, 2020–2027 (USD MILLION)
TABLE 67 GERMANY: MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.2 UK
9.3.2.1 Growing number of accredited diagnostic laboratories to propel market growth
TABLE 68 UK: LEGIONELLA TESTING INDUSTRY, BY TEST TYPE, 2020–2027 (USD MILLION)
TABLE 69 UK: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 70 UK: MARKET FOR WATER TESTING, BY TYPE, 2020–2027 (USD MILLION)
TABLE 71 UK: MARKET FOR IVD TESTING, BY TYPE, 2020–2027 (USD MILLION)
TABLE 72 UK: MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.3 FRANCE
9.3.3.1 Rising R&D expenditure and increasing demand for early diagnosis to drive market growth
TABLE 73 FRANCE: LEGIONELLA TESTING MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)
TABLE 74 FRANCE: LEGIONELLA TESTING INDUSTRY, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 75 FRANCE: MARKET FOR WATER TESTING, BY TYPE, 2020–2027 (USD MILLION)
TABLE 76 FRANCE: MARKET FOR IVD TESTING, BY TYPE, 2020–2027 (USD MILLION)
TABLE 77 FRANCE: MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.4 ITALY
9.3.4.1 Adoption of advanced diagnostic technologies to drive market growth
TABLE 78 ITALY: LEGIONELLA TESTING INDUSTRY, BY TEST TYPE, 2020–2027 (USD MILLION)
TABLE 79 ITALY: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 80 ITALY: MARKET FOR WATER TESTING, BY TYPE, 2020–2027 (USD MILLION)
TABLE 81 ITALY: MARKET FOR IVD TESTING, BY TYPE, 2020–2027 (USD MILLION)
TABLE 82 ITALY: MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.5 SPAIN
9.3.5.1 Rising geriatric population to drive market growth
TABLE 83 SPAIN: LEGIONELLA TESTING MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)
TABLE 84 SPAIN: LEGIONELLA TESTING INDUSTRY, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 85 SPAIN: MARKET FOR WATER TESTING, BY TYPE, 2020–2027 (USD MILLION)
TABLE 86 SPAIN: MARKET FOR IVD TESTING, BY TYPE, 2020–2027 (USD MILLION)
TABLE 87 SPAIN: MARKET, BY END USER, 2020–2027 (USD MILLION)
9.3.6 REST OF EUROPE
TABLE 88 ROE: LEGIONELLA TESTING INDUSTRY, BY TEST TYPE, 2020–2027 (USD MILLION)
TABLE 89 ROE: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 90 ROE: MARKET FOR WATER TESTING, BY TYPE, 2020–2027 (USD MILLION)
TABLE 91 ROE: MARKET FOR IVD TESTING, BY TYPE, 2020–2027 (USD MILLION)
TABLE 92 ROE: MARKET, BY END USER, 2020–2027 (USD MILLION)
9.4 ASIA PACIFIC
FIGURE 28 APAC: LEGIONELLA TESTING MARKET SNAPSHOT
TABLE 93 ASIA PACIFIC: LEGIONELLA TESTING INDUSTRY, BY COUNTRY, 2020–2027 (USD MILLION)
TABLE 94 ASIA PACIFIC: MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)
TABLE 95 ASIA PACIFIC: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 96 ASIA PACIFIC: MARKET, BY END USER, 2020–2027 (USD MILLION)
9.4.1 CHINA
9.4.1.1 Growing public access to modern healthcare to drive market growth
TABLE 97 CHINA: LEGIONELLA TESTING INDUSTRY, BY TEST TYPE, 2020–2027 (USD MILLION)
TABLE 98 CHINA: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 99 CHINA: MARKET FOR WATER TESTING, BY TYPE, 2020–2027 (USD MILLION)
TABLE 100 CHINA: MARKET FOR IVD TESTING, BY TYPE, 2020–2027 (USD MILLION)
TABLE 101 CHINA: MARKET, BY END USER, 2020–2027 (USD MILLION)
9.4.2 JAPAN
9.4.2.1 Universal healthcare reimbursement policy to drive market growth
TABLE 102 JAPAN: LEGIONELLA TESTING MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)
TABLE 103 JAPAN: LEGIONELLA TESTING INDUSTRY, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 104 JAPAN: MARKET FOR WATER TESTING, BY TYPE, 2020–2027 (USD MILLION)
TABLE 105 JAPAN: MARKET FOR IVD TESTING, BY TYPE, 2020–2027 (USD MILLION)
TABLE 106 JAPAN: MARKET, BY END USER, 2020–2027 (USD MILLION)
9.4.3 INDIA
9.4.3.1 Increasing private & public investments in healthcare to drive market growth
TABLE 107 INDIA: LEGIONELLA TESTING INDUSTRY, BY TEST TYPE, 2020–2027 (USD MILLION)
TABLE 108 INDIA: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 109 INDIA: MARKET FOR WATER TESTING, BY TYPE, 2020–2027 (USD MILLION)
TABLE 110 INDIA: MARKET FOR IVD TESTING, BY TYPE, 2020–2027 (USD MILLION)
TABLE 111 INDIA: MARKET, BY END USER, 2020–2027 (USD MILLION)
9.4.4 REST OF ASIA PACIFIC
TABLE 112 ROAPAC: LEGIONELLA TESTING MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)
TABLE 113 ROAPAC: LEGIONELLA TESTING INDUSTRY, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 114 ROAPAC: MARKET FOR WATER TESTING, BY TYPE, 2020–2027 (USD MILLION)
TABLE 115 ROAPAC: MARKET FOR IVD TESTING, BY TYPE, 2020–2027 (USD MILLION)
TABLE 116 ROAPAC: MARKET, BY END USER, 2020–2027 (USD MILLION)
9.5 LATIN AMERICA
9.5.1 RISING HEALTHCARE EXPENDITURE TO DRAW FOREIGN PLAYERS
TABLE 117 LATIN AMERICA: LEGIONELLA TESTING INDUSTRY, BY TEST TYPE, 2020–2027 (USD MILLION)
TABLE 118 LATIN AMERICA: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 119 LATIN AMERICA: MARKET, BY END USER, 2020–2027 (USD MILLION)
9.6 MIDDLE EAST & AFRICA
9.6.1 RISING ACCESS TO ADVANCED TECHNOLOGIES AND GROWING INVESTMENTS TO SUPPORT MARKET GROWTH
TABLE 120 MIDDLE EAST & AFRICA: LEGIONELLA TESTING MARKET, BY TEST TYPE, 2020–2027 (USD MILLION)
TABLE 121 MIDDLE EAST & AFRICA: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
TABLE 122 MIDDLE EAST & AFRICA: MARKET, BY END USER, 2020–2027 (USD MILLION)
10 COMPETITIVE LANDSCAPE (Page No. - 136)
10.1 OVERVIEW
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
10.2.1 OVERVIEW OF STRATEGIES DEPLOYED BY PLAYERS IN THE MARKET
TABLE 123 STRATEGIC DEVELOPMENTS REPORTED
10.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
FIGURE 29 REVENUE SHARE ANALYSIS OF TOP PLAYERS
10.4 MARKET SHARE ANALYSIS
10.4.1 GLOBAL MARKET
FIGURE 30 GLOBAL MARKET SHARE, BY KEY PLAYER (2021)
TABLE 124 GLOBAL LEGIONELLA TESTING INDUSTRY: DEGREE OF COMPETITION
10.5 COMPANY EVALUATION MATRIX
10.5.1 LIST OF EVALUATED VENDORS
10.5.2 STARS
10.5.3 EMERGING LEADERS
10.5.4 PERVASIVE PLAYERS
10.5.5 PARTICIPANTS
FIGURE 31 GLOBAL MARKET: COMPETITIVE LEADERSHIP MAPPING, 2021
10.6 COMPETITIVE LEADERSHIP MAPPING FOR START-UPS/SMES (2021)
10.6.1 PROGRESSIVE COMPANIES
10.6.2 STARTING BLOCKS
10.6.3 RESPONSIVE COMPANIES
10.6.4 DYNAMIC COMPANIES
FIGURE 32 GLOBAL LEGIONELLA TESTING INDUSTRY: COMPETITIVE LEADERSHIP MAPPING FOR START-UPS/SMES, 2021
10.7 COMPETITIVE BENCHMARKING
10.7.1 PRODUCT AND REGIONAL FOOTPRINT ANALYSIS
FIGURE 33 PRODUCT AND REGIONAL FOOTPRINT ANALYSIS OF TOP PLAYERS IN GLOBAL MARKET
TABLE 125 GLOBAL MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS
TABLE 126 PRODUCT FOOTPRINT ANALYSIS OF KEY PLAYERS
TABLE 127 REGIONAL FOOTPRINT ANALYSIS OF KEY PLAYERS
TABLE 128 GLOBAL MARKET: DETAILED LIST OF KEY START-UPS/SMES
10.8 COMPETITIVE SCENARIO
10.8.1 PRODUCT LAUNCHES
TABLE 129 GLOBAL MARKET: KEY PRODUCT LAUNCHES & REGULATORY APPROVALS
10.8.2 DEALS
TABLE 130 GLOBAL MARKET: KEY DEALS
10.8.3 OTHER DEVELOPMENTS
TABLE 131 LEGIONELLA TESTING MARKET: OTHER DEVELOPMENTS
11 COMPANY PROFILES (Page No. - 148)
(Business Overview, Products Offered, Recent Developments, MnM View SWOT analysis) *
11.1 KEY PLAYERS
11.1.1 INDUSTRIAL/WATER
11.1.1.1 Thermo Fisher Scientific
TABLE 132 THERMO FISHER SCIENTIFIC: BUSINESS OVERVIEW
FIGURE 34 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2021)
11.1.1.2 Merck KGAA
TABLE 133 MERCK KGAA: BUSINESS OVERVIEW
FIGURE 35 MERCK KGAA: COMPANY SNAPSHOT (2021)
11.1.1.3 Bio-Rad Laboratories
TABLE 134 BIO-RAD LABORATORIES: BUSINESS OVERVIEW
FIGURE 36 BIO-RAD LABORATORIES: COMPANY SNAPSHOT (2021)
11.1.1.4 IDEXX Laboratories
TABLE 135 IDEXX LABORATORIES: BUSINESS OVERVIEW
FIGURE 37 IDEXX LABORATORIES: COMPANY SNAPSHOT (2021)
11.1.1.5 Biomérieux SA
TABLE 136 BIOMÉRIEUX SA: BUSINESS OVERVIEW
FIGURE 38 BIOMÉRIEUX SA: COMPANY SNAPSHOT (2021)
11.1.1.6 Becton, Dickinson and Company
TABLE 137 BECTON, DICKINSON, AND COMPANY: BUSINESS OVERVIEW
FIGURE 39 BECTON, DICKINSON, AND COMPANY: COMPANY SNAPSHOT (2021)
11.1.1.7 Eurofins Scientific
TABLE 138 EUROFINS SCIENTIFIC: BUSINESS OVERVIEW
FIGURE 40 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2021)
11.1.1.8 Takara Bio
TABLE 139 TAKARA BIO: BUSINESS OVERVIEW
FIGURE 41 TAKARA BIO: COMPANY SNAPSHOT (2021)
11.1.1.9 Eiken Chemical
TABLE 140 EIKEN CHEMICAL: BUSINESS OVERVIEW
FIGURE 42 EIKEN CHEMICAL: COMPANY SNAPSHOT (2021)
11.1.1.10 Qiagen
TABLE 141 QIAGEN: BUSINESS OVERVIEW
FIGURE 43 QIAGEN: COMPANY SNAPSHOT (2021)
11.1.1.11 Genomadix
TABLE 142 GENOMADIX, INC.: BUSINESS OVERVIEW
11.2 OTHER PLAYERS
11.2.1 INDUSTRIAL/WATER
11.2.1.1 Pall Corporation (DANAHER)
11.2.1.2 Phigenics, Llc
11.2.1.3 Environmental safety technologies
11.2.1.4 Hydrosense
11.2.1.5 Accepta
11.2.1.6 Luminultra technologies
11.2.1.7 Bioalert solutions
11.2.1.8 Aquacert
11.2.1.9 Pacific water technology
11.2.1.10 DTK Water
11.2.1.11 Sens solutions
11.2.2 HEALTHCARE
11.2.2.1 Alere (ABBOTT)
TABLE 143 ABBOTT: BUSINESS OVERVIEW
FIGURE 44 ABBOTT: COMPANY SNAPSHOT (2021)
11.2.2.2 Roche Diagnostics
TABLE 144 ROCHE DIAGNOSTICS: BUSINESS OVERVIEW
FIGURE 45 ROCHE DIAGNOSTICS: COMPANY SNAPSHOT (2021)
11.2.2.3 Hologic
TABLE 145 HOLOGIC: BUSINESS OVERVIEW
FIGURE 46 HOLOGIC: COMPANY SNAPSHOT (2021)
11.2.2.4 Quidel Corporation
TABLE 146 QUIDEL CORPORATION: BUSINESS OVERVIEW
FIGURE 47 QUIDEL CORPORATION: COMPANY SNAPSHOT (2021)
11.2.2.5 Pro-Lab Diagnostics
*Details on Business Overview, Products Offered, Recent Developments, MnM View, SWOT analysis might not be captured in case of unlisted companies.
12 APPENDIX (Page No. - 201)
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3 CUSTOMIZATION OPTIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS
This study involved four major activities in estimating the current size of the legionella testing market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate segments and subsegments' market size.
Secondary Research
In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for this study.
Primary Research
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources were mainly industry experts from the core and related industries and preferred suppliers, manufacturers, distributors, service providers, technology developers, researchers, and organizations related to all segments of this industry’s value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts, C-level executives of key market players, and industry consultants, to obtain and verify the critical qualitative and quantitative information as well as assess future prospects.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the legionella testing market's total size. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
- The key players in the industry have been identified through extensive secondary research
- The revenues generated by leading players operating in the legionella testing market have been determined through primary and secondary research
- All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources
Market Size: Top-Down Approach
To know about the assumptions considered for the study, Request for Free Sample Report
Data Triangulation
After arriving at the overall market size applying the process mentioned above, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Report Objectives
- To define, describe, segment, and forecast the global legionella testing market by test type, application, end user, and region
- To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
- To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall legionella testing market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
- To forecast the size of the market segments with respect to five regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
- To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
- To track and analyze company developments such as product launches, agreements, partnerships, and acquisitions in the legionella testing market
- To benchmark players within the market using the proprietary "Competitive Leadership Mapping" framework, which analyzes market players on various parameters within the broad categories of business and product strategy
Available Customizations
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for this report:
Country Information
Legionella testing market size and growth rate estimates for countries in the Rest of Europe, the Rest of Asia Pacific, Latin America, and Middle East & Africa
Company profiles
Additional five company profiles of players operating in the legionella testing market.
Generating Response ...
Growth opportunities and latent adjacency in Legionella Testing Market
What could be hypothetic challenges of legionella testing market business in near future?